NRx Pharmaceuticals (NRXP) Provides Business Update, Reports Q2, Focuses on Reactivation & Advancement of Psychiatry Franchise

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. CRCL
6. V
7. GE
8. ASML
9. SPIR
10. NVDA

Go back to NRx Pharmaceuticals (NRXP) Provides Business Update, Reports Q2, Focuses on Reactivation & Advancement of Psychiatry Franchise
(NASDAQ: NRXP) Delayed: 3.49 --0 (-0%)
Previous Close $3.49    52 Week High $ 
Open $3.49    52 Week Low $ 
Day High $3.49    P/E N/A 
Day Low $3.49    EPS $ 
Volume 2,790